News and Events - Affimed

News

All categories

Earnings

Press Release

All years

2022

2021

2020

2019

2018

2017

2016

2015

2014

Affimed Announces Proposed Public Offering of Common Stock

February 12, 2018

Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas

February 1, 2018

Affimed Presents Data from Phase 1b Combination Study of AFM13 with Pembrolizumab at ASH

December 11, 2017

Affimed to Present at the Jefferies 2017 London Healthcare Conference

November 15, 2017

Affimed Reports Financial Results for Third Quarter 2017

November 7, 2017

Affimed to Present at the 26th Annual Credit Suisse Healthcare Conference

November 2, 2017

Affimed to Present Clinical and Preclinical Data on Immune Cell Engagers at ASH

November 2, 2017

Affimed Announces Third Quarter 2017 Financial Results and Corporate Update Conference Call

October 30, 2017

Affimed to Present at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology

September 22, 2017

Affimed Appoints Dr. Wolfgang Fischer as Chief Operating Officer

September 13, 2017

Events

All

Scientific

Investors

There are no events planned at the moment.

Webcasts More events